River Hospital, in partnership with Samaritan Medical Center in Watertown, NY, is pleased to announce that Dr. David C. Gordon, a Board-Certified Otolaryngologist, will begin seeing patients and performing surgical procedures in late September 2025.
Dr. Gordon has more than 20 years of experience treating conditions of the ears, nose, and throat (ENT), with a focus on sinus and allergy-related diseases. He also treats pediatric ENT problems, hearing and balance issues, mouth and throat conditions, and thyroid and parathyroid disorders.
“River Hospital is thrilled to welcome Dr. Gordon to our team in partnership with Samaritan Medical Center,” said Kelley Tiernan, Chief Executive Officer. “His expertise will allow us to expand the range of specialized ENT services available locally, improving timely access to high-quality care for our community and ensuring patients can receive expert treatment close to home.”
A native of the Thousand Islands region, Dr. Gordon earned his PhD at Queen’s University in Kingston, Ontario, and his medical degree at the University of Toronto, where he also completed his residency in Otolaryngology. He further trained for a year at UCLA-Harbor Medical Center in Los Angeles. Certified by the American Board of Otolaryngology, he is a member of the American Academy of Otolaryngology–Head and Neck Surgery and the American Academy of Otolaryngic Allergy.
Dr. Gordon currently practices at Samaritan’s Ear, Nose & Throat clinic in Watertown. He previously practiced in Central New York at Advanced ENT Physicians and Surgeons of CNY and served on the staff of Crouse Hospital, Upstate University Hospital, and Oneida Healthcare.
“Dr. Gordon, and the entire team at Samaritan ENT, represent the largest and most advanced practice in the region. We are so pleased to help bring these needed services to River Hospital and their patients,” states Tom Carman, President and CEO of Samaritan Medical Center.
Patients may schedule appointments with Dr. Gordon beginning now by calling River Hospital at 315-482-2094.